Martin Wilson is General Counsel of ROCKET PHARMACEUTICALS, INC.. Currently has a direct ownership of 153,918 shares of RCKT, which is worth approximately $1.61 Million. The most recent transaction as insider was on Feb 11, 2025, when has been sold 90,358 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 154K
142.16% 3M change
2408.44% 12M change
Total Value Held $1.61 Million

Martin Wilson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 11 2025
BUY
Grant, award, or other acquisition
-
90,358 Added 36.99%
153,918 Common Stock
Nov 21 2024
SELL
Open market or private sale
$15,333 $13.05 p/Share
1,175 Reduced 1.82%
63,560 Common Stock
Aug 16 2024
SELL
Open market or private sale
$18,999 $18.5 p/Share
1,027 Reduced 1.56%
64,735 Common Stock
May 16 2024
SELL
Open market or private sale
$24,470 $23.35 p/Share
1,048 Reduced 1.57%
65,762 Common Stock
May 14 2024
BUY
Exercise of conversion of derivative security
-
2,420 Added 10.29%
21,100 Common Stock
Feb 29 2024
SELL
Open market or private sale
$120,253 $29.33 p/Share
4,100 Reduced 18.0%
18,680 Common Stock
Feb 16 2024
SELL
Open market or private sale
$106,707 $29.84 p/Share
3,576 Reduced 36.82%
6,136 Common Stock
Feb 16 2024
BUY
Grant, award, or other acquisition
-
16,644 Added 42.22%
22,780 Common Stock
Feb 14 2024
SELL
Exercise of conversion of derivative security
-
9,712 Reduced 50.0%
9,712 Common Stock
Feb 14 2023
BUY
Other acquisition or disposition
-
16,947 Added 20.23%
66,810 Common Stock
Aug 12 2022
BUY
Other acquisition or disposition
-
28,763 Added 36.58%
49,863 Common Stock
MW

Martin Wilson

General Counsel
Cranbury, NJ

Track Institutional and Insider Activities on RCKT

Follow ROCKET PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RCKT shares.

Notify only if
Any

Insider Trading

Get notified when an Rocket Pharmaceuticals, Inc. insider buys or sells RCKT shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to ROCKET PHARMACEUTICALS, INC.

Track Activities on RCKT